Unichem Laboratories has informed that the United States Food and Drug Administration (USFDA) conducted an inspection at the Company’s Pithampur API facility from 24th February 2025 to 28th February 2025. The inspection closed with four observations which were more of procedural changes with none of these related to data integrity. The Company will provide the necessary response on these observations to USFDA within stipulated 15 days.
The above information is a part of company’s filings submitted to BSE.
